ESR1 |
ER; ESR; ESRA; ESTRR; Era; NR3A1 |
estrogen receptor 1 |
80.882 |
Estrogen signaling pathway;Prolactin Signaling Pathway |
2099 |
Involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. |
ESR2 |
ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 |
estrogen receptor 2 |
22.373 |
Estrogen Signaling Pathway;Prolactin Signaling Pathway |
2100 |
The gene product contains an N-terminal DNA binding domain and C-terminal ligand binding domain and is localized to the nucleus, cytoplasm, and mitochondria. |
SRC |
ASV; SRC1; THC6; c-SRC; p60-Src |
tyrosine-protein kinase Src |
22.373 |
Estrogen Signaling Pathway;Prolactin Signaling Pathway;Oxytocin Signaling Pathway; |
6714 |
May play a role in the regulation of embryonic development and cell growth. |
TP53 |
BCC7; LFS1; P53; TRP53 |
tumor protein p53 |
22.373 |
P53 Signaling Pathway |
7157 |
Mutations in this gene are associated with a variety of human cancers |
VDR |
NR1I1; PPP1R163 |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
22.373 |
Endocrine And Other Factor-Regulated Calcium Reabsorption;Mineral Absorption |
7421 |
Principally involved in mineral metabolism though the receptor regulates a variety of other metabolic pathways, such as those involved in the immune response and cancer. |